JP2022530049A5 - - Google Patents
Info
- Publication number
- JP2022530049A5 JP2022530049A5 JP2021562988A JP2021562988A JP2022530049A5 JP 2022530049 A5 JP2022530049 A5 JP 2022530049A5 JP 2021562988 A JP2021562988 A JP 2021562988A JP 2021562988 A JP2021562988 A JP 2021562988A JP 2022530049 A5 JP2022530049 A5 JP 2022530049A5
- Authority
- JP
- Japan
- Prior art keywords
- oxadiazole
- acetamide
- piperidine
- chloro
- fluorophenoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024198168A JP7878648B2 (ja) | 2019-04-23 | 2024-11-13 | 統合ストレス応答経路のモジュレーター |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19170504.5 | 2019-04-23 | ||
| EP19170504 | 2019-04-23 | ||
| EP19216875.5 | 2019-12-17 | ||
| EP19216875 | 2019-12-17 | ||
| PCT/EP2020/061150 WO2020216766A1 (en) | 2019-04-23 | 2020-04-22 | Modulators of the integrated stress response pathway |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024198168A Division JP7878648B2 (ja) | 2019-04-23 | 2024-11-13 | 統合ストレス応答経路のモジュレーター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530049A JP2022530049A (ja) | 2022-06-27 |
| JP2022530049A5 true JP2022530049A5 (cg-RX-API-DMAC7.html) | 2023-04-27 |
| JP7590343B2 JP7590343B2 (ja) | 2024-11-26 |
Family
ID=70289816
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562988A Active JP7590343B2 (ja) | 2019-04-23 | 2020-04-22 | 統合ストレス応答経路のモジュレーター |
| JP2024198168A Active JP7878648B2 (ja) | 2019-04-23 | 2024-11-13 | 統合ストレス応答経路のモジュレーター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024198168A Active JP7878648B2 (ja) | 2019-04-23 | 2024-11-13 | 統合ストレス応答経路のモジュレーター |
Country Status (15)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201920129A (zh) | 2017-09-01 | 2019-06-01 | 美商戴納立製藥公司 | 化合物、組合物及方法 |
| JP2021508336A (ja) | 2017-12-13 | 2021-03-04 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路の阻害剤 |
| US11166942B2 (en) | 2018-06-05 | 2021-11-09 | Praxis Biotech LLC | Inhibitors of integrated stress response pathway |
| EP3924341A4 (en) | 2019-02-13 | 2022-11-02 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| CR20210426A (es) * | 2019-02-13 | 2021-09-30 | Denali Therapeutics Inc | Compuestos, composiciones y métodos |
| MX2021012904A (es) * | 2019-04-23 | 2022-01-18 | Evotec Int Gmbh | Moduladores de la via de respuesta al estres integrada. |
| JP2022536663A (ja) | 2019-06-12 | 2022-08-18 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路のモジュレーター |
| WO2021165927A1 (en) * | 2020-02-21 | 2021-08-26 | Wockhardt Bio Ag | 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents |
| KR20220151635A (ko) | 2020-03-11 | 2022-11-15 | 에보텍 인터내셔널 게엠베하 | 통합 스트레스 반응 경로의 조절제 |
| MX2023004677A (es) * | 2020-10-22 | 2023-05-24 | Evotec Int Gmbh | Moduladores de la via de respuesta integrada al estres. |
| ES2997335T3 (en) | 2020-10-22 | 2025-02-17 | Evotec Int Gmbh | Modulators of the integrated stress response pathway |
| CA3195290A1 (en) | 2020-10-22 | 2022-04-28 | Holly Victoria Atton | Modulators of the integrated stress response pathway |
| TW202241857A (zh) | 2020-12-18 | 2022-11-01 | 美商戴納立製藥公司 | 化合物之固體形式 |
| WO2022212902A1 (en) * | 2021-04-02 | 2022-10-06 | Altos Labs, Inc. | Modulators of integrated stress response pathway |
| AU2023384649A1 (en) | 2022-11-21 | 2025-05-22 | Shenzhen Zhongge Biological Technology Co., Ltd. | Compound, pharmaceutical composition containing same, synthesis method therefor and use thereof |
| CN116854623B (zh) * | 2023-07-11 | 2025-08-05 | 齐鲁安替制药有限公司 | 一种阿维巴坦中间体的制备方法 |
| CN121986087A (zh) | 2023-10-13 | 2026-05-05 | 国立研究开发法人国立精神·神经医疗研究中心 | 神经保护剂 |
| AU2024406222A1 (en) | 2023-12-20 | 2026-06-04 | Bristol-Myers Squibb Company | Antibodies targeting il-18 receptor beta (il-18rβ) and related methods |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6639761B1 (en) | 1999-12-02 | 2003-10-28 | Seagate Technology Llc | Micro-actuator damping and humidity protection |
| AU2001233044A1 (en) * | 2000-01-28 | 2001-08-07 | Akkadix Corporation | Methods for killing nematodes and nematode eggs using bis-amino-1,2,4-thiadiazoles |
| US7915433B2 (en) | 2004-04-16 | 2011-03-29 | Wayne State University | Tri-substituted 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6 disubstituted pyran derivatives |
| WO2014144952A2 (en) * | 2013-03-15 | 2014-09-18 | Peter Walter | Modulators of the eif2alpha pathway |
| EA201692557A1 (ru) | 2014-07-04 | 2017-05-31 | Люпин Лимитед | Хинолизиноновые производные в качестве ингибиторов pi3k |
| WO2017046739A1 (en) | 2015-09-15 | 2017-03-23 | Glaxosmithkline Intellectual Property (No.2) Limited | Imidazolidinone derivatives as inhibitors of perk |
| TW201722957A (zh) * | 2015-09-15 | 2017-07-01 | 葛蘭素史克智慧財產(第二)有限公司 | 化學化合物 |
| TW201808888A (zh) | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TW201808914A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TW201808903A (zh) | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TWI920577B (zh) | 2016-05-05 | 2026-04-01 | 美商嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| CA3026983A1 (en) * | 2016-06-08 | 2017-12-14 | Glaxosmithkline Intellectual Property Development Limited | Chemical compounds |
| RU2018145734A (ru) * | 2016-06-08 | 2020-07-14 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Химические соединения в качестве ингибиторов atf4 пути |
| CN110730777A (zh) | 2017-06-07 | 2020-01-24 | 葛兰素史密斯克莱知识产权发展有限公司 | 作为atf4通路抑制剂的化学化合物 |
| EP3649108A1 (en) | 2017-07-03 | 2020-05-13 | GlaxoSmithKline Intellectual Property Development Limited | 2-(4-chlorophenoxy)-n-((1 -(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases |
| WO2019008506A1 (en) | 2017-07-03 | 2019-01-10 | Glaxosmithkline Intellectual Property Development Limited | N- (3- (2- (4-CHLOROPHENOXY) ACETAMIDO) BICYCLO [1.1.1] PENTAN-1-YL) -2-CYCLOBUTANE-1-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER DISEASES |
| DE102017213834A1 (de) * | 2017-08-08 | 2019-02-14 | Robert Bosch Gmbh | Sende-/Empfangseinrichtung für ein Bussystem und Verfahren zur Reduzierung einer Schwingneigung beim Übergang zwischen unterschiedlichen Bitzuständen |
| IL301709B2 (en) | 2017-08-09 | 2025-07-01 | Denali Therapeutics Inc | Compounds, compositions and methods |
| TW201920129A (zh) | 2017-09-01 | 2019-06-01 | 美商戴納立製藥公司 | 化合物、組合物及方法 |
| BR112020008825A2 (pt) | 2017-11-02 | 2020-10-20 | Calico Life Sciences Llc | moduladores da via de estresse integrada |
| MX2020004537A (es) | 2017-11-02 | 2020-10-05 | Calico Life Sciences Llc | Moduladores de la vía integrada del estrés. |
| JP2021501785A (ja) | 2017-11-02 | 2021-01-21 | カリコ ライフ サイエンシーズ エルエルシー | 統合的ストレス経路の調節剤 |
| EP3704125B1 (en) | 2017-11-02 | 2026-03-11 | Calico Life Sciences LLC | Modulators of the integrated stress pathway |
| MX2020004538A (es) | 2017-11-02 | 2020-09-18 | Calico Life Sciences Llc | Moduladores de la vía de estrés integrada. |
| UY37958A (es) | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| UY37956A (es) | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| SG11202004009TA (en) | 2017-11-02 | 2020-05-28 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| UY37957A (es) | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| JP2021508336A (ja) | 2017-12-13 | 2021-03-04 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路の阻害剤 |
| WO2019183589A1 (en) | 2018-03-23 | 2019-09-26 | Denali Therapeutics Inc. | Modulators of eukaryotic initiation factor 2 |
| WO2019193541A1 (en) | 2018-04-06 | 2019-10-10 | Glaxosmithkline Intellectual Property Development Limited | Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors |
| WO2019193540A1 (en) | 2018-04-06 | 2019-10-10 | Glaxosmithkline Intellectual Property Development Limited | Heteroaryl derivatives of formula (i) as atf4 inhibitors |
-
2020
- 2020-04-22 WO PCT/EP2020/061150 patent/WO2020216766A1/en not_active Ceased
- 2020-04-22 CN CN202080045788.1A patent/CN113993850B/zh active Active
- 2020-04-22 BR BR112021020402A patent/BR112021020402A2/pt unknown
- 2020-04-22 EP EP20719452.3A patent/EP3959198A1/en active Pending
- 2020-04-22 IL IL287379A patent/IL287379B2/en unknown
- 2020-04-22 SG SG11202111119PA patent/SG11202111119PA/en unknown
- 2020-04-22 PE PE2021001762A patent/PE20220961A1/es unknown
- 2020-04-22 MX MX2021012903A patent/MX2021012903A/es unknown
- 2020-04-22 JP JP2021562988A patent/JP7590343B2/ja active Active
- 2020-04-22 US US17/605,037 patent/US12258338B2/en active Active
- 2020-04-22 AU AU2020261234A patent/AU2020261234B2/en active Active
- 2020-04-22 KR KR1020217037824A patent/KR20220004105A/ko active Pending
-
2021
- 2021-10-21 MX MX2024015479A patent/MX2024015479A/es unknown
- 2021-10-22 ZA ZA2021/08151A patent/ZA202108151B/en unknown
- 2021-10-22 CL CL2021002772A patent/CL2021002772A1/es unknown
- 2021-10-26 CO CONC2021/0014292A patent/CO2021014292A2/es unknown
-
2024
- 2024-11-13 JP JP2024198168A patent/JP7878648B2/ja active Active
-
2025
- 2025-02-19 US US19/057,900 patent/US20250188071A1/en active Pending
-
2026
- 2026-04-23 AU AU2026203062A patent/AU2026203062A1/en active Pending